1-4 of 4
Vinay Jain, MBBS, MD
Close
Sort by
Journal Articles

Low Relapse Rate in Younger Patients ≤ 60 Years Old with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) Treated with Crenolanib and Cytarabine/Anthracycline Chemotherapy

Eunice S. Wang, MD, Martin S. Tallman, MD, Richard M. Stone, MD, Roland B. Walter, MD PhD, Chatchada Karanes, MD, Vinay Jain, MBBS, MD, Robert H. Collins, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 566.
https://doi.org/10.1182/blood.V130.Suppl_1.566.566
Published: 2017
Journal Articles

Pharmacokinetic and Pharmacodynamic Analysis of Ocaratuzumab in 50 Patients with Relapsed Follicular Lymphoma and Low-Affinity FcγRIIIa (CD16a) Polymorphisms.

Minna Du, Adrienne O'Reilly, MS, Phuong H Le, MS, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2012) 120 (21): 2750.
https://doi.org/10.1182/blood.V120.21.2750.2750
Published: 2012
Journal Articles

Anti-Tumor Activity of Low Dose Ocaratuzumab in Previously Treated Follicular Lymphoma Patients with Low-Affinity CD16 Polymorphisms

Phuong H Le, MS, Andres Forero-Torres, MD, Nam H. Dang, MD, PhD, Mitchell R Smith, MD, PhD, Brian K Link, MD, Kristen N. Ganjoo, MD, Kensei Tobinai, MD, PhD, Minna Du, Adrienne O'Reilly, MS, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2012) 120 (21): 4884.
https://doi.org/10.1182/blood.V120.21.4884.4884
Published: 2012
Journal Articles

Sustained Depletion of B-Cells by a Humanized, Fc-Engineered Anti-CD20 Antibody, AME-133v, in Patients with Relapsed Follicular Lymphoma

Jennifer Wayne, MS, Kristen N. Ganjoo, MD, Andres Forero, MD, Brad Pohlman, MD, Sven de Vos, MD, PhD, Susan P. Carpenter, PhD, James E Wooldridge, MD, Shashidhara Marulappa, DVM, MVSc, MBA, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2011) 118 (21): 4977.
https://doi.org/10.1182/blood.V118.21.4977.4977
Published: 2011